Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET

Company Participants

Adam Brown - IR

Dan Burton - CEO

Bryan Hunt - CFO

Conference Call Participants

Anne Samuel - JPMorgan

Ryan Daniels - William Blair

Jessica Tassan - Piper Sandler

Cindy Motz - Goldman Sachs

Elizabeth Anderson - Evercore

Stephanie Davis - SVB Securities

Richard Close - Canaccord Genuity

John Ransom - Raymond James

Daniel Grosslight - Citi

David Larsen - BTIG

Dev Weerasuriya - Berenberg

Operator

Good day, and thank you for standing by. Welcome to the Health Catalyst First Quarter 2022 Earnings Conference Call. [Operator Instructions] Please be advised today's conference may be recorded. [Operator Instructions]

I'd now like to hand the conference over to Adam Brown, Senior Vice President of Investor Relations and Financial Planning and Analysis.

Adam Brown

Good afternoon, and welcome to Health Catalyst's earnings conference call for the first quarter of 2022, which ended on March 31, 2022. My name is Adam Brown. I'm the Senior Vice President of Investor Relations and Financial Planning and Analysis for Health Catalyst. And with me on the call is Dan Burton, our Chief Executive Officer; and Bryan Hunt, our Chief Financial Officer. A complete disclosure of our results can be found in our press release issued today as well as in our related Form 8-K furnished to the SEC. Both of which are available on the Investor Relations section of our website at ir.healthcatalyst.com. As a reminder, today's call is being recorded, and a replay will be available following the conclusion of the call.

During today's call, we will make forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 regarding trends, strategies, the impact of the COVID-19 pandemic on our business and results of operations, our pipeline conversion rates and our general anticipated performance of the business. These forward-looking statements are based on management's current views and expectations as of today and should not be relied upon as representing our views as of any subsequent date. We disclaim any obligation to update any forward-looking statements or outlook. Actual results may materially differ.

Please refer to the risk factors in our Form 10-K for the year ended December 31, 2021, filed with the SEC on March 1, 2022, and our Form 10-Q for the quarter ended March 31, 2022, which will be filed with the SEC today. We will also refer to certain non-GAAP financial measures to provide additional information to investors. A reconciliation of these non-GAAP financial measures to their most comparable GAAP measures is provided in our press release.